MENU
+Compare
ANIP
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$62.56
Change
+$0.44 (+0.71%)
Capitalization
1.43B

ANIP ANI Pharmaceuticals Forecast, Technical & Fundamental Analysis

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals... Show more

ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ANIP with price predictions
Jun 13, 2025

ANIP's RSI Indicator climbs out of oversold territory

The RSI Oscillator for ANIP moved out of oversold territory on May 30, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 02, 2025. You may want to consider a long position or call options on ANIP as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ANIP just turned positive on June 03, 2025. Looking at past instances where ANIP's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

ANIP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 199 cases where ANIP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

ANIP moved below its 50-day moving average on May 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANIP crossed bearishly below the 50-day moving average on May 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.305) is normal, around the industry mean (62.115). P/E Ratio (79.847) is within average values for comparable stocks, (88.968). ANIP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (2.537) is also within normal values, averaging (19.096).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANIP is expected to report earnings to fall 15.88% to $1.43 per share on August 06

ANI Pharmaceuticals ANIP Stock Earnings Reports
Q2'25
Est.
$1.43
Q1'25
Beat
by $0.36
Q4'24
Beat
by $0.18
Q3'24
Beat
by $0.26
Q2'24
Beat
by $0.07
The last earnings report on May 09 showed earnings per share of $1.70, beating the estimate of $1.34. With 150.69K shares outstanding, the current market capitalization sits at 1.43B.
A.I. Advisor
published General Information

General Information

a manufacturer of branded and generic prescription pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
210 Main Street West
Phone
+1 218 634-3500
Employees
642
Web
https://www.anipharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTMX34.55-0.37
-1.06%
Artisan Mid Cap Investor
GSESX61.68-0.81
-1.30%
Goldman Sachs US Equity Insights Svc
RAFGX43.39-0.60
-1.36%
American Funds AMCAP R6
VYRBX25.33-0.38
-1.48%
VY® Baron Growth R6
NWHHX14.49-0.27
-1.83%
Nationwide Bailard Cogntv Val Instl Svc

ANIP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+0.71%
ORGO - ANIP
48%
Loosely correlated
-3.15%
PRGO - ANIP
40%
Loosely correlated
-2.20%
DRRX - ANIP
38%
Loosely correlated
-3.91%
EBS - ANIP
31%
Poorly correlated
-5.30%
AMRX - ANIP
27%
Poorly correlated
-2.64%
More